Edition:
United States

AmerisourceBergen Corp (ABC.N)

ABC.N on New York Stock Exchange

83.54USD
23 Aug 2019
Change (% chg)

$-2.01 (-2.35%)
Prev Close
$85.55
Open
$85.46
Day's High
$86.37
Day's Low
$83.10
Volume
360,982
Avg. Vol
335,151
52-wk High
$94.84
52-wk Low
$69.36

About

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company's segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment... (more)

Overall

Beta: 0.97
Market Cap(Mil.): $17,634.10
Shares Outstanding(Mil.): 219.11
Dividend: 0.37
Yield (%): 1.81

Financials

  ABC.N Industry Sector
P/E (TTM): 20.99 21.54 38.68
EPS (TTM): 3.83 -- --
ROI: 10.14 11.95 55.93
ROE: 38.47 13.92 65.79

Cardinal Health warns ongoing opioid-related lawsuits to hit business

Drug distributor Cardinal Health Inc warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits.

Aug 20 2019

UPDATE 1-Cardinal Health warns ongoing opioid-related lawsuits to hit business

Aug 20 Drug distributor Cardinal Health Inc warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits.

Aug 20 2019

U.S. Drug distributors propose $10 billion to end state lawsuits over opioids: Bloomberg

Drug wholesalers AmerisourceBergen Corp , McKesson Corp and Cardinal Health Inc have proposed a $10 billion settlement for claims that they played a part in the U.S. opioid epidemic, Bloomberg reported on Tuesday, citing people familiar with negotiations.

Aug 06 2019

AmerisourceBergen loses bid to keep parts of N.Y. opioid case secret

AmerisourceBergen has lost a bid to keep secret material related to the drug distributor's internal program for monitoring for suspicious orders in a lawsuit by New York's attorney general accusing the company of fueling the opioid epidemic.

May 24 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates